The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Novel multitarget small molecule inhibitor LCI133 and synthetic lethality in endometrial carcinoma via CDK9/PI3K axis.
 
Ritchie Delara
No Relationships to Disclose
 
Dhananjaya Pal
No Relationships to Disclose
 
Krishnaiah Maddeboina
No Relationships to Disclose
 
R. Wendel Naumann
Consulting or Advisory Role - Agenus; AstraZeneca; Bristol-Myers Suibb; Clovis Oncology; Eisai; Genelux; GlaxoSmithKline/Tesaro; GOG Partners; Laekna Therapeutics; Merck Sharp & Dohme; OncoMed; Seagen; Sutro Biopharma
Speakers' Bureau - Seagen
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline/Tesaro (Inst); Gynecologic Oncology Group (Inst); Mersana (Inst); OncoMed (Inst); Sutro Biopharma (Inst)
 
Erin Crane
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - GlaxoSmithKline; Merck
 
Jubilee Brown
Honoraria - Caris Life Sciences; Clovis Oncology; Genentech/Roche; GlaxoSmithKline/Tesaro; Verastem
Consulting or Advisory Role - Caris Life Sciences; Clovis Oncology; Genentech/Roche; GlaxoSmithKline/Tesaro; Verastem
Speakers' Bureau - Eisai
Research Funding - Genentech; Tesaro
 
Page Mangum Arditti
No Relationships to Disclose
 
Hailey L. Dryden
No Relationships to Disclose
 
Bharath Yada
No Relationships to Disclose
 
Wei Sha
No Relationships to Disclose
 
Donald Durden
Stock and Other Ownership Interests - SignalRx pharmaceuticals
Patents, Royalties, Other Intellectual Property - SignalRx pharmaceuticals
 
Cody McHale
No Relationships to Disclose